SBRI Centre of Excellence’s Post

Sharing an insightful interview with Memorial Sloan Kettering President & CEO Dr. Selwyn Vickers discussing advancements in cancer treatment. As someone battling prostate cancer, I find the progress in this field both hopeful and insightful. This interview sheds light on the complexities of cancer, its treatment, and the importance of research. Highly recommended for anyone interested in the latest developments in oncology. #CancerAwareness #ProstateCancer #OncologyResearch #CancerTreatment #MedicalInnovation #HealthcareLeaders #CancerSurvivor #MemorialSloanKettering #CancerResearch #FightCancer

📚 EU Missions are a new way to bring concrete solutions to some of the greatest global challenges such as Climate Change and Cancer. They will deliver impact by putting research and innovation into a new role, combined with new forms of governance and collaboration, as well as by engaging citizens. 🔎 The MammoScreen Project is part of the EU Mission: Cancer, which has the aim of improving the lives of more than 3 million people, from patients to caregivers, through prevention and cure by 2030. Read more here 👉 bit.ly/MammoScreenProject

👋 #AACR24! Our team has arrived at #booth 4117, do not hesitate to visit us and join our two poster presentations! See you there! Don’t hesitate to contact Romain Teinturier to arrange a meeting. #AACR24 #lifescience #oncology #CRO #partnering #drugdevelopment #3Rs #ethical #NAM #PDXmodel 

Going to #AACR24 this year, April 5-10? Join our team at the American Association for Cancer Research (AACR) Annual Meeting. ✨ Aurélie QUENTIN, Frank Visser, Emmanuel Chereul and Romain Teinturier are looking forward to meeting you at booth #4117. Don't hesitate to contact them to set up a meeting and learn how ERBC Group can strategize your approach to make your cancer drug development a success. Don’t miss our poster presentations: 📅 Monday Apr 8, 2024, 9:00 AM - 12:30 PM. “The immuno-AVI-PDX, an innovative patient-derived xenograft model for preclinical immuno-oncology studies” 📅 Wednesday Apr 10, 2024, 9:00 AM - 12:30 PM. “Micro-implantation of patient tumor samples into the avian embryo, a fast and reliable alternative in vivo technology for preclinical studies on melanoma and follicular lymphoma” Don't miss this opportunity to connect oncology solutions, early! See you there! #lifescience #oncology #CRO #partnering #drugdevelopment #3Rs #ethical #NAM #PDXmodel 

Please consider making a donation, no matter how small, to raise money for the fight against Cancer. Your contribution can make a significant impact in advancing Cancer research and increasing awareness. To donate, please list my name in the comments section so we can track your support. Together, we can make a difference. #CancerAwareness #CancerNinjas #CancerResearch

👋 We can't wait to attend #AACR24, @Romain Teinturier, Project Manager, ERBC Group, Oncofactory will be there at booth #4117 to discuss with you how our pioneering predictive avian PDX platform accelerates drug development while respecting the 3Rs. Don’t hesitate to contact Romain Teinturier to arrange a meeting. Don't miss our two poster presentations on our unique and innovative platform. Join us to find out how the ERBC (European Research Biology Centre) group can accelerate your non-clinical studies. #lifescience #oncology #CRO #partnering #drugdevelopment #3Rs #ethical #NAM #PDXmodel 

#AACR24, I will be there! Join me at booth #4117 to learn how ERBC (European Research Biology Center) Group facilitates the evaluation of cancer drug candidates from preclinical proof of concept to market success. Let's network and explore opportunities together. See you there! 🚀 #lifescience #oncology #CRO #partnering #drugdevelopment 

#AACR24 - Only 3 days left to meet the American Association for Cancer Research community! Don't miss your chance to connect with our experts at #booth4117 and discuss how ERBC Group can help you build a strategy for successful cancer drug development by building on the most relevant translational models, selecting the best predictive biomarkers, and choosing state-of-the-art technologies. In addition, join our poster presentations: 📅 Monday Apr 8, 2024, 9:00 AM - 12:30 PM. “The immuno-AVI-PDX, an innovative patient-derived xenograft model for preclinical immuno-oncology studies” 📅 Wednesday Apr 10, 2024, 9:00 AM - 12:30 PM. “Micro-implantation of patient tumor samples into the avian embryo, a fast and reliable alternative in vivo technology for preclinical studies on melanoma and follicular lymphoma” Don’t hesitate to arrange a meeting with ✨ Aurélie QUENTIN, Frank Visser, Emmanuel Chereul and Romain Teinturier who will be there. #lifescience #oncology #CRO #partnering #drugdevelopment #3Rs #ethical #NAM #PDXmodel 

Witness the forward-thinking next generation that is saying NO TO TOBACCO, as they highlight how they are leading the change on protecting children from their generation onwards from the interferences by the tobacco industry #shankaracancerhospitals #NoSmokingChallenge #nosmoke #nosmokingplease #novape #notcool #notcoolbro #industryinfluence #industry #TobaccoFreeGeneration #tobaccofreekids #TobaccoFreeFuture #tobaccofreelife #NextGenerationLeaders #nextgenerationleadership #smokefreelife #SmokeFreeAndVapeFreeMe #SmokeFree2024 #vapeoff #healthylifestyle

🌟 Exciting Update from the LUCIA EU Project Advisory Board Meeting! 🌟   Our recent meeting with the LUCIA Project Advisory Board was a productive session filled with insightful discussions and valuable contributions towards our project objectives. Here's a brief overview of what took place:   💡 Updates on the First Year of LUCIA: Yoav Broza from Technion - Israel Institute of Technology presented comprehensive updates on the progress made during the project's first year together with Hossam Haick. Engaging questions and comments from all members enriched our understanding and provided valuable perspectives. 🗣 Stakeholder Contact List Input: We sought input on our stakeholder contact list, organisations and projects not to miss in the field of (lung) cancer, ensuring inclusivity and breadth in our outreach efforts. 💬 Discussion on the first LUCIA Social Lab Workshop Concept: A dynamic discussion led by our Ivett and Emad explored the concept for our upcoming Social Lab workshop. We discussed barriers to the implementation of LUCIA technologies to real-life settings to include in our discussions with representatives of (lung) cancer organisations and EU-level initiatives. 🙏 Thank you to all our Advisory Board members for your invaluable guidance and contributions @Johanna Mattson @Kwun Fong Mehdi Snene, Ph.D.. Together, we're advancing towards understanding lung cancer-related risk factors and their impact! #LUCIAProject #AdvisoryBoardMeeting #Collaboration #Innovation